Features Partner Sites Information LinkXpress
Sign In

Mesh Matrix Treats Hard-to-Heal Wounds

By HospiMedica International staff writers
Posted on 27 Feb 2014
Print article
Image: The MatriStem Multilayer Wound Matrix device is designed for deep, hard-to-heal wounds (Photo courtesy of ACell).
Image: The MatriStem Multilayer Wound Matrix device is designed for deep, hard-to-heal wounds (Photo courtesy of ACell).
A new multilayer matrix device accommodates moderate to heavy wound exudate and provides effective contouring functionality in wound treatment.

The MatriStem Multilayer Wound Matrix device is designed to maintain and support a healing environment through constructive tissue remodeling for both acute and chronic wounds. The device is comprised of naturally occurring urinary bladder matrix (UBM), the basement membrane of porcine urinary bladder tissue, which is disinfected, packaged, and sterilized to produce a non-cross-linked, completely resorbable, acellular extracellular matrix (ECM) scaffold that is rich with naturally occurring collagens and proteins.

UBM provides several distinguishable characteristics, including the recruitment of progenitor cells, chemotactic and mitogenic activities, and site-specific tissue remodeling. UBM also has the ability to facilitate the body’s own regenerative capabilities and help restore normal site-appropriate tissue while avoiding scar tissue formation; the ability to be used "off-the-shelf" and stored at room temperature, with an approximate two-year shelf life; and superior ease-of-use characteristics.

MatriStem is easy to prepare, apply, and fixate, and requires no special handling requirements. It is indicated for all types of wound management, including pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds, trauma wounds, and the reinforcement of soft tissue where weakness exists in urological, gynecological, and gastroenterological anatomy. The MatriStem Multilayer Wound Matrix device is a product of ACell (Columbia, MD, USA), and has been approved by the US Food and Drug Administration (FDA).

“ACell has developed MatriStem Multilayer Wound Matrix to address an unmet need in the area of acute and chronic wound care management,” said Jim DeFrancesco, CEO of ACell. “The launch of this new product provides a new option for physicians treating patients suffering from deep, hard-to-heal wounds.”

Related Links:


Print article


Critical Care

view channel

New Program Reduces COPD Hospital Readmissions

A treatment plan designed to help hospitals reduce chronic obstructive pulmonary disorder (COPD) related readmissions and costs also improves patient outcomes and quality of life. The COPD Seamless Treatment and Exacerbation Prevention (STEP) Plan, a partnership between Nonin Medical (Minneapolis, MN, USA) and Tri-anim... Read more

Women's Health

view channel

Droplet PCR System Identifies Fetal Genetic Data

A new study describes a simple, accurate, and low risk blood test that can detect fetal blood group, sex, and genetic conditions from a maternal blood sample. Developed by researchers at Plymouth University (United Kingdom), the new noninvasive fetal Rh blood group and D antigen (RhD) genotyping test can help prevent... Read more

Health IT

view channel
Image: Amblyz occlusion glasses (Photo courtesy of Xpand).

Electronic Glasses Effective in Amblyopia Treatment

A new study shows that programmable digital glasses for treating amblyopia (lazy eye) work as well as eye patching. Researchers at Indiana University (Bloomington, IN, USA) conducted a randomized clinical... Read more


view channel
Image: The BCH/Fractured FX ETV model (Photo courtesy of Boston Children\'s Hospital).

Boston Children's Hospital Partners with Fractured FX

Boston Children’s Hospital (BCH; MA, USA) has launched a collaboration with special effects company Fractured FX (Monrovia, CA, USA) to develop ultra-realistic models of patients' anatomy for surgical... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.